MiMedx amends bylaws to address universal proxy rules and make technical changes

MIMEDX GROUP, INC.

Board approved amended and restated Bylaws effective February 16, 2023.
Amendments clarify compliance with SEC Rule 14a-19 universal proxy rules for director nominations.
Incorporate changes from Amendment No. 1 adopted May 27, 2021.
Include technical, modernizing, and clarifying updates to the Bylaws.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MIMEDX GROUP, INC.: Amended and restated Bylaws to address universal proxy rules, incorporate prior Amendment No. 1, and include technical clarifying changes (effective 2023-02-16).

Change: bylaw amendment
Effective: 2023-02-16

Exact text from the filing

On February 16, 2023, the Board of Directors (the “ Board ”) of MiMedx Group, Inc. (the “ Company ”) approved an amendment and restatement of the Company’s amended and restated Bylaws (as amended and restated, the “ Amended and Restated Bylaws ”), which became effective the same day.

View on SEC.gov

Browse all governance changes →

MIMEDX GROUP, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-046821

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.